BNBX on OTC

BNB Plus Corp

Logo: bnb.plus4

American publicly traded digital asset management company listed on NASDAQ (BNBX).1

$0.10 down 0.01 (6.00%)Price as of Oct 15, 2026 at 17:33 UTC

Last updated Oct 16, 2026.

Overview

$2.1MRevenue, fiscal 20255
-$15.2MNet income, fiscal 20255
1983Founded1

Compare with AVAX ONE TECHNOLOGY LTD., FG Communities Holdings Inc. or Chaince Digital Holdings Inc., or pick any stock.

  • TickerBNBX on OTC1
  • Industrycryptocurrency, financial services1
  • HeadquartersCatherine's Gate1
  • Websitewww.bnb.plus
  • Legal formcorporation1
  • Incorporated inDE6
  • Business address25 Health Sciences Drive, Stony Brook, Ny6
  • Filer categoryNon-accelerated filer, Smaller reporting company6

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

39.3%Gross margin5
-750.9%Operating margin5
-709.5%Net margin5
1.1%Revenue growth, 20255
-657.8%Return on equity5

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

Supply Chain brought in 54% of the revenue BNB Plus Corp broke down this way in fiscal 2025.

  1. Supply Chain$1.1M554%down 5% from 2024
  2. Large Scale DNA Production$612.4K529%up 5% from 2024
  3. Research and Development Services (Over-Time)$375.8K518%up 21% from 2024
Products and services by year
Products and services20242025
Supply Chain$1.2M$1.1M
Large Scale DNA Production$584.1K$612.4K
Research and Development Services (Over-Time)$311.2K$375.8K

Business segments

DNA Tagging and Security Products brought in 54% of the revenue BNB Plus Corp broke down this way in fiscal 2025.

  1. DNA Tagging and Security Products$1.1M554%down 6% from 2024
  2. Therapeutic DNA Production$988.1K546%up 10% from 2024
Business segments by year
Business segments20242025
DNA Tagging and Security Products$1.2M$1.1M
Therapeutic DNA Production$895.4K$988.1K

Regions

Asia and other brought in 48% of the revenue BNB Plus Corp broke down this way in fiscal 2025.

  1. Asia and other$1.0M548%up 3% from 2024
  2. Americas$1.0M547%up 6% from 2024
  3. Europe$105.6K55%down 39% from 2024
Regions by year
Regions20242025
Asia and other$989.2K$1.0M
Americas$951.9K$1.0M
Europe$172.4K$105.6K

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue7¢$1.3M
  • Research and development32¢$6.0M
  • Selling, general and admin58¢$10.9M
  • Income tax4¢$684.1K

Out of $2.1M in revenue.5 The company lost money this year.

Financial statements

Revenue78910115$2.1M in 2025−45% since 2018
0$5.0M$10.0M$15.0M$20.0M2018: $3.9M$3.9M20182019: $5.4M$5.4M2019+38%2020: $1.9M$1.9M2020−64%2021: $9.0M$9.0M2021+367%2022: $18.2M$18.2M2022+101%2023: $13.4M$13.4M2023−26%2024: $2.1M$2.1M2024−84%2025: $2.1M$2.1M2025+1%
Gross profit910115$838.9K in 2025−81% since 2021
0$2.0M$4.0M$6.0M2021: $4.5M$4.5M20212022: $5.1M$5.1M2022+13%2023: $5.5M$5.5M2023+9%2024: $974.8K$974.8K2024−82%2025: $838.9K$838.9K2025−14%
Operating income7128910115-$16.0M in 2025+38% since 2018
-$20.0M-$15.0M-$10.0M-$5.0M02018: -$11.6M-$11.6M20182019: -$9.1M-$9.1M2019−22%2020: -$12.5M-$12.5M2020+37%2021: -$13.3M-$13.3M2021+6%2022: -$14.0M-$14.0M2022+5%2023: -$11.0M-$11.0M2023−22%2024: -$13.7M-$13.7M2024+25%2025: -$16.0M-$16.0M2025+17%
Net income7128910115-$15.2M in 2025+30% since 2018
-$20.0M-$15.0M-$10.0M-$5.0M02018: -$11.7M-$11.7M20182019: -$8.6M-$8.6M2019−26%2020: -$13.0M-$13.0M2020+51%2021: -$14.3M-$14.3M2021+10%2022: -$8.3M-$8.3M2022−42%2023: -$9.9M-$9.9M2023+20%2024: -$7.0M-$7.0M2024−30%2025: -$15.2M-$15.2M2025+117%

Every line of the income statement in the latest annual report, as filed.5

Period ending2025-09-302024-09-30
Total revenues$2.1M$2.1M
Cost of product revenues$1.3M$1.1M
Gross profit$838.9K$974.8K
Selling, general and administrative$10.9M$11.0M
Research and development$6.0M$3.6M
Total operating expenses$16.9M$14.6M
LOSS FROM OPERATIONS-$16.0M-$13.7M
Interest income$192.9K$120.5K
Transaction costs allocated to warrant liabilities-$633.2K
Unrealized gain on change in fair value of warrants classified as a liability$319.6K$9.4M
Unrealized loss on change in fair value of warrants classified as a liability-warrant modification-$394.0K
Loss on issuance of warrants-$1.6M
Other expense, net-$106.6K-$8.9K
Loss before provision for income taxes-$15.6M-$6.8M
Income tax provision benefit$684.1K
Net loss from continuing operations-$15.0M-$6.8M
Net loss from discontinued operations, net of tax-$392.7K-$300.5K
NET LOSS-$15.3M-$7.1M
Less: Net loss attributable to noncontrolling interest$188.5K$95.8K
NET LOSS attributable to BNB Plus Corp.-$15.2M-$7.0M
Deemed dividend related to warrant modifications-$54.3M-$233.1K
NET LOSS attributable to common stockholders-$69.5M-$7.2M
Net loss per share attributable to common stockholders-continuing operations - basic (in dollars per share)-$133-$1.3K
Net loss per share attributable to common stockholders-continuing operations - diluted (in dollars per share)-$133-$1.3K
Net loss per share attributable to common stockholders-discontinued operations - basic (in dollars per share)-$1-$57
Net loss per share attributable to common stockholders-discontinued operations - diluted (in dollars per share)-$1-$57
Net loss income per share attributable to common stockholders - basic (in dollars per share)-$134.23-$1,366.42
Net loss income per share attributable to common stockholders - diluted (in dollars per share)-$134.23-$1,366.42
Weighted average shares outstanding- basic (in shares)517.7K shares5.3K shares
Weighted average shares outstanding- diluted (in shares)517.7K shares5.3K shares

Compare BNB Plus Corp with another company

Leadership

Who has led BNB Plus Corp, and when. Pick a name to see everywhere that person has worked.

Board members and other officers (1)

Employees over time

  • 2025261

Former names

  • APPLIED DNA SCIENCES INCDec 13, 2002 to Nov 10, 20256
  • PROHEALTH MEDICAL TECHNOLOGIES INCMay 30, 2001 to Dec 18, 20026
  • DCC ACQUISITION CORPJun 11, 1999 to May 4, 20016
  • DATALINK CAPITAL CORP/TX/May 26, 1998 to Feb 8, 19996
  • Applied DNA Sciences, Inc.until Nov 20251

Timeline

  1. 1983Founded Founded1

Recent filings

  1. Oct 2, 20268-K
  2. Oct 2, 20268-K/A
  3. Oct 1, 20268-K
  4. Oct 1, 2026RW
  5. Sep 16, 20264 OWNERSHIP DOCUMENT
  6. Sep 16, 20264 OWNERSHIP DOCUMENT
  7. Sep 16, 20264 OWNERSHIP DOCUMENT
  8. Sep 14, 20263 OWNERSHIP DOCUMENT
  9. Sep 14, 20263 OWNERSHIP DOCUMENT
  10. Sep 14, 20263 OWNERSHIP DOCUMENT
  11. Sep 4, 2026SCHEDULE 13D/A
  12. Sep 3, 20268-K
  13. Aug 27, 2026SCHEDULE 13D/A
  14. Aug 14, 2026SCHEDULE 13G/A
  15. Aug 13, 202610-Q

Every filing from the last three years, summarized. The full record is on SEC EDGAR.2